BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17719734)

  • 1. Contrast-enhanced versus systematic transrectal ultrasound-guided prostate cancer detection: an overview of techniques and a systematic review.
    Heijmink SW; Barentsz JO
    Eur J Radiol; 2007 Sep; 63(3):310-6. PubMed ID: 17719734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies.
    Loch T
    World J Urol; 2007 Aug; 25(4):375-80. PubMed ID: 17694312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer.
    Zhao HX; Xia CX; Yin HX; Guo N; Zhu Q
    Eur J Radiol; 2013 Nov; 82(11):e641-7. PubMed ID: 23916578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer.
    Gao Y; Liao XH; Lu L; Wang L; Ma Y; Qin HZ; Yan X; Guo P
    Clin Radiol; 2016 Mar; 71(3):258-64. PubMed ID: 26738964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
    Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
    Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies.
    Kaufmann S; Kruck S; Kramer U; Gatidis S; Stenzl A; Roethke M; Scharpf M; Schilling D
    Urol Int; 2015; 94(3):319-25. PubMed ID: 25227711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.
    Heijmink SW; van Moerkerk H; Kiemeney LA; Witjes JA; Frauscher F; Barentsz JO
    Eur Radiol; 2006 Apr; 16(4):927-38. PubMed ID: 16391907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
    Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
    Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
    Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
    Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
    Mitterberger M; Pinggera GM; Horninger W; Bartsch G; Strasser H; Schäfer G; Brunner A; Halpern EJ; Gradl J; Pallwein L; Frauscher F
    J Urol; 2007 Aug; 178(2):464-8; discussion 468. PubMed ID: 17561137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transrectal ultrasound and core biopsies for the diagnosis of prostate cancer. A study of pretreatment investigation strategy for patients with suspected prostate cancer.
    Norberg M
    Acta Radiol Suppl; 1994; 393():1-21. PubMed ID: 8184698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
    Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
    J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of prostate tumor targeting strategies using magnetic resonance imaging-targeted, transrectal ultrasound-guided fusion biopsy.
    Martin PR; Cool DW; Fenster A; Ward AD
    Med Phys; 2018 Mar; 45(3):1018-1028. PubMed ID: 29363762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer?
    Delongchamps NB; Portalez D; Bruguière E; Rouvière O; Malavaud B; Mozer P; Fiard G; Cornud F;
    J Urol; 2016 Oct; 196(4):1069-75. PubMed ID: 27079582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection.
    Gayet M; van der Aa A; Schmitz P; Beerlage HP; Schrier BP; Mulders PF; Mischi M; Wijkstra H
    World J Urol; 2016 Sep; 34(9):1255-60. PubMed ID: 26847183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
    Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
    BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.